Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France

• Loïg Gaugain,

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Amaris Consulting, Montréal, Canada

  ⨯
• Hélène Cawston ,

  Roles Conceptualization, Methodology, Validation, Writing – original draft, Writing – review & editing

  * E-mail: helene.cawston@amaris.com

  Affiliation Amaris Consulting, Paris, France

  https://orcid.org/0000-0003-0860-8160

  ⨯
• Coline Dubois de Gennes,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft

  Affiliation Amaris Consulting, London, United-Kingdom

  ⨯
• Javier Sanchez Alvares,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation Roche SAS, Boulogne-Billancourt, France

  ⨯
• Pierre Nahon,

  Roles Conceptualization, Methodology, Validation, Writing – review & editing

  Affiliations AP-HP, Liver Unit, Bobigny, France, Université Sorbonne Paris Nord, Bobigny, France

  ⨯
• Benjamin Mazaleyrat,

  Roles Methodology, Supervision, Validation, Writing – original draft

  Affiliation Roche SAS, Boulogne-Billancourt, France

  ⨯
• Clément Le Dissez

  Roles Validation, Writing – original draft, Writing – review & editing

  Affiliation Roche SAS, Boulogne-Billancourt, France

  ⨯